Figma Shares Indicated To Open $105/$110
Robert Gamgort, Executive Chairman of Keurig Dr Pepper Inc. (NASDAQ:KDP), a beverage giant with a $45 billion market cap and impressive 55.6% gross profit margins according to InvestingPro, recently sold 416,000 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The transaction, which took place on March 4, 2025, was executed at a weighted average price of $34.29 per share, resulting in a total sale value of approximately $14.26 million. The sale price was notably close to InvestingPro’s Fair Value estimate, suggesting the stock is currently fairly valued.
The sale was conducted under a pre-arranged trading plan, known as a Rule 10b5-1 plan, which Gamgort adopted on October 30, 2024. This type of plan allows company insiders to set up a trading schedule for selling stocks to avoid potential accusations of insider trading.
In addition to the sale, Gamgort engaged in other transactions involving Keurig Dr Pepper stock. On March 3, 2025, he acquired a total of 103,738 shares through the conversion of restricted stock units (RSUs). These RSUs converted into common stock on a one-for-one basis as per the company’s Omnibus Stock Incentive Plan of 2019.
Furthermore, Gamgort disposed of 38,527 shares to cover tax obligations related to the vesting of the RSUs, at a price of $34.13 per share, totaling approximately $1.31 million.
Following these transactions, Gamgort’s direct ownership in Keurig Dr Pepper stands at 3,237,066 shares. Additionally, he holds indirect ownership through trusts, which account for 746,721 shares. With a "FAIR" financial health rating from InvestingPro and analysts projecting profit growth this year, investors can access detailed insider trading analysis and 7 additional ProTips through the platform’s comprehensive research reports.
In other recent news, Keurig Dr Pepper reported its fourth-quarter 2024 earnings, surpassing market expectations with an earnings per share (EPS) of $0.58, slightly above the forecasted $0.57. The company also exceeded revenue projections, reporting $4.07 billion compared to the anticipated $4.02 billion. Additionally, Keurig Dr Pepper completed a significant public secondary offering, resulting in the sale of 73 million shares and gross proceeds of approximately $2.7 billion, although the company did not receive any proceeds from this transaction. Following the offering, three board members affiliated with JAB Holding Company, the selling stockholder, resigned, reducing the board size from eleven to eight directors.
In analyst activity, Jefferies increased its price target for Keurig Dr Pepper to $41 while maintaining a Buy rating, citing strong organic growth and better-than-expected earnings. Similarly, Citi analysts raised their price target to $41 from $40, also keeping a Buy rating, and noted the company’s robust performance in the Refreshment Beverages segment despite facing coffee inflation. Both firms highlighted Keurig Dr Pepper’s strategic initiatives and pricing strategies as key factors contributing to the positive outlook.
These developments reflect ongoing changes in Keurig Dr Pepper’s corporate governance and ownership structure, as well as the company’s continued focus on strategic growth and operational performance amidst a competitive market environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.